Member Info for E_AL

adzy2k11 ..... where did you go ???

We love ya hahaah

Tbh I didnt see that one coming hahahahaahahahaha

Nice one adzy.. whats next? NMC hospitals don't give freebies to patients ;)

So whats the plan now ? Keep detramping in every other post or ........? ha

adzy2k11 the sp is £8.15 at the moment, I guess you'll have to deramp in double shifts now lol

"No they didn't. They hold that amount"

Yep, its been given to them for free lol

State Street Global Advisors & Affiliates bought 1.22616% of the company's shares !

NMC Health disclosed preliminary buyout approaches from private equity firms KKR and GK Investment on Monday, only weeks after questions raised by short-seller Muddy Waters hit the firm.

NMC is the largest private healthcare company in the United Arab Emirates and operates a network of clinics and hospitals, specialized maternity and fertility clinics, and long-term care homes hospitals across 19 countries.

A bruising short-selling attack by Muddy Waters launched two months ago has seen the company's market value fall to 1.5 billion pounds ($1.9 billion), a far cry from its peak value of about 8.4 billion pounds in August 2018. Here is a timeline of events leading up to Monday's announcement:

1975 Bavaguthu Raghuram (BR) Shetty establishes New Medical Centre (NMC), the first private healthcare facility in UAE.

2012 NMC becomes the first company from Abu Dhabi to join the London Stock Exchange.

2015 NMC bids for regional rival Al Noor Hospitals Group, sparking a race with South Africa's Mediclinic, before eventually pulling out overvaluation concerns.

2017 NMC is promoted to the blue-chip FTSE 100 index.

2018 NMC raises $2 billion to be used for general corporate purposes and partly to refinance existing debt, sources say

2019 October

NMC guides to double-digit revenue and core earnings growth in 2020. Dec. 17

U.S. short-selling firm Muddy Waters, founded by American Carson Block, acquires a short position in NMC, criticising the healthcare group's financial statements and wiping a third off the value of the company's share price. Dec. 18

NMC stands by its forecasts for 2019 and 2020 and announces a share buyback. Dec. 19

NMC calls the Muddy Waters report criticizing the healthcare group's financial statements "false and misleading". Dec. 23

NMC calls for an independent review of its finances. 2020

Jan. 8 Two major shareholders launched a discounted share sale in NMC worth 375 million pounds.

Jan. 17 Independent review committee hires FBI ex-boss Louis Freeh.

Feb. 4 NMC says 2019 trading is in line with expectations.

Feb. 10 NMC says its co-chair and founder Shetty had stepped back from its board after he informed NMC of potentially inaccurate reporting of his holdings.

https://www.devdiscourse.com/article/health/868791-timeline-nmc-healths-expansion-and-ailments

Nice wave of buys has gone through in the last 30 minutes.

No reason for the drop at all and the company has sufficient cash in the back to carry on its operations. I think the share price will bounce back up soon to at least one of these two support levels:

Pivot Point 2nd Support Point 9.15p
Pivot Point 1st Support Point 9.54p

"By no later than 5.00 p.m. on 9 March 2020 the US buyout group KKR, & Swiss investment house GK Investment Holding will have to make an offer, otherwise they'll miss the their chance "

... The clock is ticking ; )

Pavol Krupa, the investment company (KGI) which is preparing complaint at FCA and FBI regarding Muddy Waters allegations just tweeted this :

@Pavol_Krupa
Replying to
@muddywatersre
Someone did a good job in preparing a takeover. $NMC
@NMCHealthcare

"

This is exactly what I've been telling you guys over the weekend:

"@ZaksTradersCafe

AlignResearch: Just looking at 5 year technicals on #NMC per attached. Each time the stock has approached near 20% RSI evel a rally of 20-30% has ensued. Stock is presently most oversold on record.

(TA Chart attached)

https://twitter.com/ZaksTradersCafe/status/1226802023603064832?s=20 "

2 take overs ;)

opening BID is £8 so far ;)

"Received two preliminary takeover approaches this morning from US buyout group KKR, & Swiss investment house GK Investment Holding."

"The Company's operations continue to perform strongly, and the Company expects to report full-year 2019 results in-line with management's expectations."

Happy with today's confirmations

"The Company's operations continue to perform strongly, and the Company expects to report full-year 2019 results in-line with management's expectations."

Interesting !

Kefi is a good investment for the middle/ long term

Guys , I don’t recommend buying TRX at the moment. They are running out of cash, fund in the piggy to keep them running till the end of March and they are unable you secure fund. We dunno yet what damage the cyber attack caused and whether the hackers managed to copy any IPs .. don’t get me wrong I like the company and I do believe they have a niche & highly demanded product but they don’t have enough cash to meet the demand so I’m expecting a placing in the near future. Get out if you can break even and buy back once the company sorts out it’s finance

I absolutely agree Kaaba, this is what Align Research posted today:

“ With full year 2020 EPS projected at approx £1.40 per share and Free Cash Flow per share at over £1.20 per share for the same year, even with net debt (cash adjusted) of approx $1.7bn and adding the $660m of lease liabilities the EV of NMC is now just £3.3bn. Set against an EBITDA projection of $745m for 2020 results (and that was recently reiterated) in a potential equity take out value of around 8-10 times based on similar sector/peer deals. This equates to £4.6bn to £5.7bn or just under £14 a share to £18.70 per share.

The company’s cash flow we believe IS real given the large share buy-back commitment (indeed it would be very hard for the company to not now follow through on this) and the purchasing of $90m of convertible bonds back only a few months ago. It is hard to fudge that type of cash outflow to third parties.

Our sense is that something concrete is going to break on the news front imminently regarding the multitude bid/investment party interest in the shares and at 700p – if you can buy anywhere near here on Monday morning, this level is likely to generate meaningful upside for new buyers in our opinion. We are long.”

I would like to stress on the fact that TA is on our side atm & RSI is 20% .. NMC’s RSI NEVER dropped below 20% since listing & it ALWAYS bounced back up from this oversold level... again when it comes to the stock market anything can happen really but knowing that RSI never dropped below 20% since listing gives me more confidence that it’s very likely we’ll see some sp recovery tomorrow

Freddie, you're welcome!
Sunday is a working day in UAE so I'd expect the company's BOD & IR to be busy preparing press releases for tomorrow to defend its positing on FTSE100 and to support the share price recovery.

Good MCap recovery will strength the company's position in any takeover negotiations.

Last week Betaville were reporting interest from a number of private equity firms at prices of between £14 & £19 per share together with potential bidders for their Spanish fertility business Eugin. Now, there has been further commentary this weekend in the Mail on Sunday detailing interest from KKR. This line from the article hints at multitude party interest – “Sources said KKR may face competition from other US-based private equity firms for NMC Health. Apollo, led by Leon Black, has talked to NMC Health about a variety of deals, varying from purchasing a stake in the business to buying the whole group”.

The mooted value in this instance at £2bn being somewhat less at just shy of £9.50 a share. We doubt the stock will go for such a low price as we set out below.

With full year 2020 EPS projected at approx £1.40 per share and Free Cash Flow per share at over £1.20 per share for the same year, even with net debt (cash adjusted) of approx $1.7bn and adding the $660m of lease liabilities the EV of NMC is now just £3.3bn. Set against an EBITDA projection of $745m for 2020 results (and that was recently reiterated) in a potential equity take out value of around 8-10 times based on similar sector/peer deals.

**** This equates to £4.6bn to £5.7bn or just under £14 a share to £18.70 per share.

The company’s cash flow we believe IS real given the large share buy-back commitment (indeed it would be very hard for the company to not now follow through on this) and the purchasing of $90m of convertible bonds back only a few months ago. It is hard to fudge that type of cash outflow to third parties.

Our sense is that something concrete is going to break on the news front imminently regarding the multitude bid/investment party interest in the shares and at 700p – if you can buy anywhere near here on Monday morning, this level is likely to generate meaningful upside for new buyers.

We are long.

http://www.alignresearch.co.uk/nmc-healthcare/nmc-healthcare-valuing-the-equity-with-more-bidders-now-in-the-frame/